Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

NCT00248313 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: Rapamune®

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer